PTX — Prescient Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$56.78m
- AU$47.98m
- AU$0.14m
Australia's Prescient Therapeutics jumps on getting orphan drug designation by FDA
Brief: Prescient Therapeutics Ltd Seeks An Immediate Trading Halt Regarding A Placement
Australia's Prescient Therapeutics jumps on collaboration with US-based cancer centre
Brief: Prescient Therapeutics Announces Strategic Collaboration With MD Anderson Cancer Center
Australia's Prescient Therapeutics slumps on discounted capital raise
Brief: Prescient Therapeutics Says It Signs Agreement With Thermo Fisher
Brief: Prescient Therapeutics Says It Entered Manufacturing Services Agreement
Australia's Prescient Therapeutics soars on orphan drug designation for cancer therapy
Brief: Prescient Therapeutics Says Us FDA Grants Orphan Drug Designation To Ptx-100 For Ptcl
Australia's Prescient Therapeutics rises on getting U.S. patent
Australia's Prescient Therapeutics surges on clinical study expansion
Australia Stock Exchange release from PRESCIENT : Investor Presentation
Australia Stock Exchange release from PRESCIENT : PRE_NR Ends: 09:52:36
Australia Stock Exchange release from PRESCIENT : Appendix 4D and Half Year Financial Report
Australia Stock Exchange release from PRESCIENT : PRE_NR Ends: 10:24:31
Australia Stock Exchange release from PRESCIENT : December 2021 Quarterly Update and Appendix 4C
Australia Stock Exchange release from PRESCIENT THERAP : Application for quotation of securities - PTX
Australia Stock Exchange release from PRESCIENT THERAP : Section 708A Cleansing Statement
Australia Stock Exchange release from PRESCIENT THERAP : Application for quotation of securities - PTX